Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower.
http://www.biosciencetechnology.com/news/2013/06/pluristem-slumps-fda-suspends-stem-cell-study
http://www.biosciencetechnology.com/news/2013/06/pluristem-slumps-fda-suspends-stem-cell-study
No comments:
Post a Comment